0001171843-21-008009.txt : 20211116 0001171843-21-008009.hdr.sgml : 20211116 20211116162009 ACCESSION NUMBER: 0001171843-21-008009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211112 FILED AS OF DATE: 20211116 DATE AS OF CHANGE: 20211116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kavuru Vimal CENTRAL INDEX KEY: 0001697184 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35776 FILM NUMBER: 211416371 MAIL ADDRESS: STREET 1: 11 MAACKA DRIVE CITY: HOLMDEL STATE: NJ ZIP: 07733 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acasti Pharma Inc. CENTRAL INDEX KEY: 0001444192 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 3009, BOUL. DE LA CONCORDE EAST STREET 2: SUITE 102 CITY: LAVAL STATE: A8 ZIP: H7E 2B5 BUSINESS PHONE: 450-686-4555 MAIL ADDRESS: STREET 1: 3009, BOUL. DE LA CONCORDE EAST STREET 2: SUITE 102 CITY: LAVAL STATE: A8 ZIP: H7E 2B5 4 1 ownership.xml X0306 4 2021-11-12 0 0001444192 Acasti Pharma Inc. ACST 0001697184 Kavuru Vimal C/O ACASTI PHARMA INC. 3009 BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7T 2B5 QUEBEC, CANADA 1 0 0 0 Stock Options (Right to Buy) 1.63 2021-11-12 4 A 0 42100 0 A 2031-11-12 Class A Common Shares 42100 42100 D Based on conversion of exercise price of C$2.05 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7959 on the date of grant. Stock options granted on 11/12/2021 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable with respect to 25% of the shares every three months. /s/ Jason Comerford, attorney-in fact for Mr.Kavuru 2021-11-16